ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $4.13 billion. The enterprise value is $5.44 billion.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.48 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Current Share Class | 24.48M |
| Shares Outstanding | 24.48M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 5.92% |
| Owned by Institutions (%) | 102.19% |
| Float | 22.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.74 |
| Forward PS | 1.72 |
| PB Ratio | 2.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 24.33 |
| P/OCF Ratio | 16.20 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 20.17, with an EV/FCF ratio of 32.01.
| EV / Earnings | n/a |
| EV / Sales | 2.32 |
| EV / EBITDA | 20.17 |
| EV / EBIT | 118.47 |
| EV / FCF | 32.01 |
Financial Position
The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.81.
| Current Ratio | 2.29 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 5.67 |
| Debt / FCF | 9.77 |
| Interest Coverage | 0.43 |
Financial Efficiency
Return on equity (ROE) is -5.35% and return on invested capital (ROIC) is 0.76%.
| Return on Equity (ROE) | -5.35% |
| Return on Assets (ROA) | 0.66% |
| Return on Capital (ROIC) | 0.76% |
| Revenue Per Employee | $167,150 |
| Profits Per Employee | -$7,929 |
| Employee Count | 14,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, ICU Medical has paid $97,000 in taxes.
| Income Tax | 97,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +95.83% in the last 52 weeks. The beta is 0.66, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +95.83% |
| 50-Day Moving Average | 176.54 |
| 200-Day Moving Average | 131.62 |
| Relative Strength Index (RSI) | 38.28 |
| Average Volume (20 Days) | 241,062 |
Short Selling Information
The latest short interest is 652,487, so 2.66% of the outstanding shares have been sold short.
| Short Interest | 652,487 |
| Short Previous Month | 703,438 |
| Short % of Shares Out | 2.66% |
| Short % of Float | 2.89% |
| Short Ratio (days to cover) | 2.85 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.34 billion and -$111.01 million in losses. Loss per share was -$4.57.
| Revenue | 2.34B |
| Gross Profit | 769.11M |
| Operating Income | 45.91M |
| Pretax Income | -98.35M |
| Net Income | -111.01M |
| EBITDA | 269.59M |
| EBIT | 45.91M |
| Loss Per Share | -$4.57 |
Full Income StatementBalance Sheet
The company has $324.84 million in cash and $1.66 billion in debt, giving a net cash position of -$1.34 billion or -$54.53 per share.
| Cash & Cash Equivalents | 324.84M |
| Total Debt | 1.66B |
| Net Cash | -1.34B |
| Net Cash Per Share | -$54.53 |
| Equity (Book Value) | 2.05B |
| Book Value Per Share | 83.76 |
| Working Capital | 708.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $255.11 million and capital expenditures -$85.23 million, giving a free cash flow of $169.88 million.
| Operating Cash Flow | 255.11M |
| Capital Expenditures | -85.23M |
| Free Cash Flow | 169.88M |
| FCF Per Share | $6.94 |
Full Cash Flow StatementMargins
Gross margin is 32.87%, with operating and profit margins of 1.96% and -4.74%.
| Gross Margin | 32.87% |
| Operating Margin | 1.96% |
| Pretax Margin | -4.74% |
| Profit Margin | -4.74% |
| EBITDA Margin | 11.52% |
| EBIT Margin | 1.96% |
| FCF Margin | 6.84% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.02% |
| Shareholder Yield | -1.02% |
| Earnings Yield | -2.69% |
| FCF Yield | 4.11% |
Dividend DetailsAnalyst Forecast
The average price target for ICU Medical is $173.00, which is 2.46% higher than the current price. The consensus rating is "Buy".
| Price Target | $173.00 |
| Price Target Difference | 2.46% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 2.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
ICU Medical has an Altman Z-Score of 1.74 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.74 |
| Piotroski F-Score | 5 |